Name | Rilonacept |
---|
Description | Rilonacept (Arcalyst), a dimeric fusion protein, is a interleukin 1 inhibitor. Rilonacept consists of the ligand-binding domains of the extracellular portions of the IL-1R components linked to the Fc portion of human IgG1. Rilonacept can be used for the research of cryopyrin-associated periodic syndromes[1]. |
---|---|
Related Catalog | |
Target |
IL-1 |
In Vitro | Rilonacept 通过充当结合 IL-1β 并阻止其与细胞表面受体相互作用的可溶性诱饵受体来阻断 IL-1α 信号传导,从而减少炎症过程[1]。 |
References |
No Any Chemical & Physical Properties |